Clinical Trial Update: Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating rituximab, pentostatin, cyclophosphamide, and lenalidomide in previously untreated B-cell chronic lymphocytic leukemia or s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Lenalidomide (lenalidomide)
• Pentostatin (pentostatin)
• Rituximab (rituximab)

Snippet

Sponsor: Mayo Clinic | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2012-04-11